| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/09/2003 | WO2002026997A3 Dsp-16 dual-specificity phosphatase |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002018648A3 Analysis of binding interactions |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2002012885A3 Simple methods for the drug monitoring of gpiib/iiia-receptor antagonists |
| 01/09/2003 | WO2002012566A3 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 01/09/2003 | WO2002008407A3 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/09/2003 | WO2002004670A3 Improved capture and detection of target nucleic acid in dipstick assays |
| 01/09/2003 | WO2002002816A3 Methods for identifying mitochondrial divalent cation transporters |
| 01/09/2003 | WO2002000618A3 Progesterone receptor-regulated gene expression and methods related thereto |
| 01/09/2003 | WO2001098763A3 Aggregate dilatometer device and methods of testing |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001084459A3 Method for determining significant losses in bone density |
| 01/09/2003 | WO2001081369A3 Peptide potentiation of acid-sensory ion channel in pain |
| 01/09/2003 | WO2001070776A3 Nimr compositions and their methods of use |
| 01/09/2003 | WO2001067100A9 Bax degradation involvement in tumor survival and progression |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001056697A9 Apparatus and method for ejecting sample well trays |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001053817A9 Methods of and apparatus for separating and detecting nucleic acid |
| 01/09/2003 | WO2001009609A3 Hepatitis c viral antigen immunoassay detection systems |
| 01/09/2003 | US20030009774 Trangenic rodent for use as model in evaluation of xenobiotics |
| 01/09/2003 | US20030009296 Database and system for storing, comparing and displaying genomic information |
| 01/09/2003 | US20030009295 System and method for retrieving and using gene expression data from multiple sources |
| 01/09/2003 | US20030009293 Reference database |
| 01/09/2003 | US20030009291 Structural prediction of allosterism |
| 01/09/2003 | US20030009286 Soil characteristics survey device and soil characteristics survey method |
| 01/09/2003 | US20030009112 Device and electrode arrangement for electrophysiological studies |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008864 Treatment of diseases involving cyst formation |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008823 For determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1F receptor |
| 01/09/2003 | US20030008820 Methods and products related to FGF dimerization |
| 01/09/2003 | US20030008807 Novel signaling pathway for the production of inflammatory pain and neuropathy |
| 01/09/2003 | US20030008806 Inhibitors of phosphodiesterases (PDEs) such as papaverine for treatment of drug dependence and psychological disorders |
| 01/09/2003 | US20030008725 Measurement of the coefficient of restitution of a golf club |
| 01/09/2003 | US20030008415 Determination of protein s concentration; obtain ligand, incubate with sample, detect complex formation, determine protein concentration |
| 01/09/2003 | US20030008414 Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and methods of use |
| 01/09/2003 | US20030008413 Methods of making and using substrate surfaces having covalently bound polyelectrolyte films |
| 01/09/2003 | US20030008411 Combinatorial synthesis system |
| 01/09/2003 | US20030008410 Immunoassay apparatus, kit and methods |
| 01/09/2003 | US20030008408 Macromolecule for use in the detection of preferential particles in sample |
| 01/09/2003 | US20030008407 Non-invasive diagnostic and monitoring system based on odor detection |
| 01/09/2003 | US20030008405 Fluorescent metal sensors, and methods of making and using the same |
| 01/09/2003 | US20030008404 Method of measuring an impurity profile of a semiconductor wafer and program for measuring an impurity profile of a semiconductor wafer |
| 01/09/2003 | US20030008401 Quantitative microspectroscopy |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008373 APOA1-interacting proteins and use thereof |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030008340 Metabolic biosensor and uses thereof |
| 01/09/2003 | US20030008339 Detection of preferential particles in sample; obtain reaction mixture, incubate with binding particles, detect complex, monitor and measure luminescence |
| 01/09/2003 | US20030008338 Assay methods and kits therefor |
| 01/09/2003 | US20030008337 Analytical system based upon spore germination |
| 01/09/2003 | US20030008336 Detection of ischemic damage in sample; obtain animal, monitor concentration of succinate, compare to control, evaluate for ischemic damage |
| 01/09/2003 | US20030008335 Biosensor for use in the detection preferential particles in quartz crystal microbalance |
| 01/09/2003 | US20030008333 Screening method |
| 01/09/2003 | US20030008332 Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 01/09/2003 | US20030008331 Directed evolution biosensors |
| 01/09/2003 | US20030008328 Quantitative in vitro bone induction assay |
| 01/09/2003 | US20030008325 Cell growth, induction and lysis in an antibody-coated microplate for use in an elisa |
| 01/09/2003 | US20030008324 Caspase-7-interacting protein and use thereof |
| 01/09/2003 | US20030008323 Chemical-library composition and method |
| 01/09/2003 | US20030008321 Antibody for use as tool in immunoassay |
| 01/09/2003 | US20030008319 Sequence based screening |
| 01/09/2003 | US20030008318 Determination of the number of copies of a preferential nucleotide sequence in sample; obtain sample, incubate with solid support and probe, detecting the amount of binding of the first and second labelled complementary |
| 01/09/2003 | US20030008317 Detection of modulator of translation; generate translation reaction mixture, incubate with modulator, detect polypeptide generation, generation of polypeptides indicates translation has not been inhibited |
| 01/09/2003 | US20030008316 Anthraquinone and its derivatives |
| 01/09/2003 | US20030008314 Fiber-optic sensor array |
| 01/09/2003 | US20030008305 Oligonucleotide and method for detecting verotoxin |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | US20030008300 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008296 Method for determining polymorphism |
| 01/09/2003 | US20030008288 Detection and treatment of polycystic kidney disease |
| 01/09/2003 | US20030008284 Polynucleotides related to colon cancer |
| 01/09/2003 | US20030008283 Method for screening for drug candidates for modulating transcription factor activity |
| 01/09/2003 | US20030008282 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2003 | US20030008280 Detection of viral enzymatic activity in sample; obtain sample, incubate with substrate, monitor generation of reaction product, the presence of product indicates enzyme activity |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008278 Method of amplifying or detecting HIV-1 RNA |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
| 01/09/2003 | US20030008272 Detecting therapeutic agents in sample; obtain cell, expose to oxidatve stress, incubate with therapeutic agent, monitor response, reduced damage due to oxidative stress indicates preventive or therapeutic agent |
| 01/09/2003 | US20030008159 Analyzing, binding to nucleic acid, nucleotides |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/09/2003 | US20030007978 Quantiative analysis; genetic engineering |
| 01/09/2003 | US20030007942 Topical applying to skins |
| 01/09/2003 | US20030007895 Substrate to attenuate radiation; absorber layer |
| 01/09/2003 | US20030007893 Measuring blood, glucose concentration; prevention air gaps |
| 01/09/2003 | US20030007892 UA cup |
| 01/09/2003 | US20030007150 Measurement systems and methods for determining component particle concentrations in a liquid |
| 01/09/2003 | US20030006192 Artificial membrane support having G-protein coupled receptor immobilized thereon, wherein receptor is immobilized such that its tertiary structure after immobilization permits binding to ligands that are bound by receptor in vivo |
| 01/09/2003 | US20030006143 Directed assembly of functional heterostructures |
| 01/09/2003 | US20030005964 Low-cost stream switching system |